Growth Metrics

Anaptysbio (ANAB) Gains from Investment Securities (2016 - 2025)

Anaptysbio filings provide 9 years of Gains from Investment Securities readings, the most recent being $61.6 million for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities changed N/A year-over-year to $61.6 million, compared with a TTM value of $1.5 million through Dec 2025, down 80.66%, and an annual FY2025 reading of $301202.0, down 95.05% over the prior year.
  • Gains from Investment Securities hit $61.6 million in Q4 2025 for Anaptysbio, up from -$61.6 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $61.6 million in Q4 2025, with the low at -$61.6 million in Q3 2025.
  • Median Gains from Investment Securities over the past 5 years was $2.9 million (2023), compared with a mean of $2.5 million.
  • The largest YoY upside for Gains from Investment Securities was 218.75% in 2024 against a maximum downside of 45.69% in 2024.
  • Year by year, Gains from Investment Securities stood at $20.7 million in 2021, then plummeted by 76.53% to $4.9 million in 2022, then skyrocketed by 170.4% to $13.1 million in 2023, then grew by 5.3% to $13.8 million in 2024, then surged by 345.94% to $61.6 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $61.6 million, -$61.6 million, and $1.5 million for Q4 2025, Q3 2025, and Q1 2025 respectively.